Accent Microcell Ltd

Accent Microcell Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Accent Microcell Ltd

₹ 233 2.46%
21 May - close price
Company website NSE - SME: ACCENTMIC
About

Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]

Key Points

Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.

Website NSE - SM
  • Market Cap ₹ 490 Cr.
  • Current Price ₹ 233
  • High / Low ₹ 315 / 180
  • Stock P/E 14.8
  • Book Value ₹ 92.6
  • Dividend Yield 0.43 %
  • ROCE 23.7 %
  • ROE 18.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 51.2% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024 Mar 2025
107 139 126 139
87 119 107 115
Operating Profit 20 20 19 23
OPM % 18% 14% 15% 17%
1 2 3 3
Interest 1 0 0 0
Depreciation 2 2 2 2
Profit before tax 17 19 20 24
Tax % 18% 17% 16% 32%
14 16 16 17
EPS in Rs 9.13 7.64 7.83 7.89
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
131 133 166 197 246 265
122 122 153 178 206 223
Operating Profit 9 11 13 19 39 42
OPM % 7% 8% 8% 10% 16% 16%
4 2 2 2 3 6
Interest 3 3 3 3 1 0
Depreciation 3 4 4 4 4 4
Profit before tax 6 6 8 15 37 44
Tax % 31% 20% 22% 17% 17% 24%
4 5 6 12 30 33
EPS in Rs 9.72 11.16 4.56 9.45 14.34 15.71
Dividend Payout % 0% 0% 18% 8% 7% 0%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 17%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 51%
3 Years: 78%
TTM: 7%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -19%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 23%
Last Year: 18%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 13 13 21 21
Reserves 21 19 37 143 174
30 24 23 13 2
22 38 37 28 32
Total Liabilities 77 95 111 205 228
29 30 31 29 48
CWIP 0 0 0 2 13
Investments 0 0 0 0 0
48 64 79 174 168
Total Assets 77 95 111 205 228

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
5 5 15 8 11 25
-2 -6 -4 -4 -82 -9
-2 -2 -10 -4 72 -14
Net Cash Flow 1 -3 1 -1 1 2

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 60 38 56 80 90
Inventory Days 78 128 128 82 76
Days Payable 80 97 106 48 42
Cash Conversion Cycle 58 68 79 114 124
Working Capital Days 59 54 73 96 102
ROCE % 27% 31% 24%

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Mar 2025
55.09% 55.09% 55.09%
0.03% 0.02% 0.01%
1.62% 1.66% 2.19%
43.26% 43.23% 42.70%
No. of Shareholders 2,4182,9992,834

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls